Antarctic Marine-Derived Fungi: Metabolomic Signatures and Antibiofilm-Driven Anti-Infective Potential Against Drug Resistant Pathogens
Marine Drugs · 02.08.2026 · 24 (8) · 267
DOI: 10.3390/md24080267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 02.08.2026. Verfasst von İbrahim S Uras und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmacognosy, Ağrı İbrahim Çeçen University, 04100 Ağrı, Turkey. Hauptthemen laut MEDLINE: Biofilms, Fungi, Aquatic Organisms, Anti-Bacterial Agents. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Turkish Antarctic Expeditions project, Foundation for Science and Technology, Applied Molecular Biosciences Unit.
Abstract (Originalsprache)
Antarctic marine-derived fungi represent an underexplored reservoir of bioactive secondary metabolites shaped by extreme environmental pressures. In this study, nine fungal isolates obtained from Antarctic macroalgae, lichens, sponge tissue, and sediments were evaluated for their antimicrobial, anticancer, antibiofilm, and metabolomic profiles. Untargeted LC–MS/MS molecular networking (GNPS) revealed a chemically rich metabolome, dominated by alkaloids, followed by polyketides, meroterpenoids, and diketopiperazines, with Penicillium crustosum (A15A) emerging as a major biosynthetic contributor. The annotation of structurally diverse metabolites, including roquefortines, viridicatin derivatives, andrastins, and multiple diketopiperazines, highlights the metabolic plasticity of Antarctic fungi. Anticancer evaluation indicated cytotoxicity, with Aspergillus awamori (A30), Alternaria malorum (A36), and Cladosporium malorum (A38) displaying activity toward HCT 116 colorectal cancer cells at IC50 ≥ 30 µg/mL. Extracts were screened against methicillin-resistant Staphylococcus aureus (MRSA, COL), methicillin-susceptible S. aureus (MSSA, NCTC8325 4), and Escherichia coli K12, revealing low to no activity against these pathogens. Six of the nine isolates exhibited strong antibiofilm activity without inhibiting planktonic bacterial growth, indicating selective biofilm inhibition against MSSA and meeting the criteria for clinical developmental “hits”. Biofilm inhibition ranged from 81.10% to 98.50%, with A15A showing the highest activity (98.50% at 250 µg/mL), followed by A36 (91.16% at 31.35 µg/mL). Botrytis sp. (A22A), P. chrysogenum (A7), Ulocladium microsporum (A24B), and A30 also demonstrated strong antibiofilm activity (81.10–85.89%). To our knowledge, this is the first report describing antibiofilm activity of Antarctic fungal extracts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Pharmacognosy, Ağrı İbrahim Çeçen University, 04100 Ağrı, Turkey.
- Department of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, São Paulo 05508-000, SP, Brazil.
- Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University of Lisbon, Campus Caparica, 2819-516 Caparica, Portugal.
- UCIBIO-Applied Molecular Biosciences Unit, Chemistry and Life Sciences Departments, NOVA School of Science and Technology, NOVA University of Lisbon, Campus Caparica, 2819-516 Caparica, Portugal.
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.
- Faculty of Pharmacy, Department of Pharmacognosy, Lokman Hekim University, 06560 Ankara, Turkey.
ORCID-Profile: İbrahim S Uras, Catarina M Luís, Cecília M P Rodrigues, Rita G Sobral, Belma Konuklugil, Susana P Gaudêncio
Förderung
- the Turkish Antarctic Expeditions project
- Foundation for Science and Technology
- Applied Molecular Biosciences Unit
- La Caixa Foundation
- São Paulo Research Foundation
- National Council for Scientific and Technological Development
- Brazilian Federal Agency for Support and Evaluation of Graduate Education
- Ministry of Science, Industry and Technology of the Republic of Turkey
Zitieren
APA
Uras, İ. S., Candido, P. H. S., Luís, C. M., Marques, V., Rodrigues, C. M. P., Sobral, R. G., Baurmeister, A., Konuklugil, B., & Gaudêncio, S. P. (2026). Antarctic Marine-Derived Fungi: Metabolomic Signatures and Antibiofilm-Driven Anti-Infective Potential Against Drug Resistant Pathogens. Marine Drugs, 24(8), 267. https://doi.org/10.3390/md24080267
Vancouver
Uras İS, Candido PHS, Luís CM, Marques V, Rodrigues CMP, Sobral RG, et al. Antarctic Marine-Derived Fungi: Metabolomic Signatures and Antibiofilm-Driven Anti-Infective Potential Against Drug Resistant Pathogens. Marine Drugs. 2026;24(8):267. doi:10.3390/md24080267
BibTeX
@article{Uras2026,
author = {Uras, İbrahim S and Candido, Pedro H S and Luís, Catarina M and Marques, Vanda and Rodrigues, Cecília M P and Sobral, Rita G and Baurmeister, Anelize and Konuklugil, Belma and Gaudêncio, Susana P},
title = {Antarctic Marine-Derived Fungi: Metabolomic Signatures and Antibiofilm-Driven Anti-Infective Potential Against Drug Resistant Pathogens},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {8},
pages = {267},
doi = {10.3390/md24080267}
}
EUVIMED